Research & Development

Is CAR T-cell Therapy the Future of Cancer Treatment?
Research & Development Is CAR T-cell Therapy the Future of Cancer Treatment?

The battle against cancer is one that has engaged the global medical community for decades, and with the emergence of Chimeric Antigen Receptor (CAR) T-cell therapy, we stand on the precipice of a significant revolution in the way cancer is treated. This immunotherapy transforms a patient's

How Is PhoreMost's SITESEEKER Shaping Retinal Therapy?
Research & Development How Is PhoreMost's SITESEEKER Shaping Retinal Therapy?

In a significant stride for medical science, PhoreMost Ltd., a biotechnological innovator, has forged a promising path in retinal therapy through its alliance with the pharmaceutical giant Boehringer Ingelheim. The joint venture, which kicked off in January 2020, has recently celebrated a crucial

Retro Biosciences Partners with Multiply Labs for Longevity
Research & Development Retro Biosciences Partners with Multiply Labs for Longevity

Introduction Retro Biosciences, a pioneering biotech company, has embarked on an ambitious journey to extend human lifespan by a decade through innovative approaches to combat cellular aging. Its strategic partnership with Multiply Labs, a firm celebrated for advanced automation and robotic

Advancing Disease Treatment: The Future of NK Cell Therapy
Research & Development Advancing Disease Treatment: The Future of NK Cell Therapy

The relentless progress of medical technology regularly unlocks new arenas in the battle against disease, with one of the most notable being the potent capabilities of Natural Killer (NK) cell therapies. As critical members of the immune system, NK cells have become the cornerstone of an innovative

Can-Fite BioPharma Ratings Split Amid Financial Struggles
Management & Regulatory Can-Fite BioPharma Ratings Split Amid Financial Struggles

In the dynamic realm of biopharmaceutical investments, the diverging analyst ratings for Can-Fite BioPharma (NYSE: CANF) underscore the complex calculus of betting on drug development firms. The stock analysis firm StockNews.com has planted its flag with a "hold" rating, signaling a

Surging Lab Automation Market to Hit $11.31B by 2031
Research & Development Surging Lab Automation Market to Hit $11.31B by 2031

The lab automation market is a rapidly growing field, expected to reach a staggering $11.31 billion by 2031. This growth is driven by several factors, including increased R&D spending, the rising prevalence of chronic and infectious diseases, higher demand for lab automation, and significant

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later